Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Irbesartan and Hydrochlorothiazide Tablets

Approval Number

国药准字H20244074

Company浙江京新药业股份有限公司

Registration Date

June 18, 2024

Drug Information

Generic Name

厄贝沙坦氢氯噻嗪片

Dosage Form

片剂

Strength

每片含厄贝沙坦150mg，氢氯噻嗪12.5mg

Drug Type

化学药品

Registration Date

June 18, 2024

Company Information

Applicant Company

Company Name浙江京新药业股份有限公司

Company Address

浙江省新昌县羽林街道新昌大道东路800号

Manufacturing Company

Company Name浙江京新药业股份有限公司

Company Address

浙江省新昌县羽林街道新昌大道东路800号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy